BioSpace News Archive

Cybin Announces Successful Completion of In Vivo Preclinical Studies for its Deuterated Psilocybin Analog CYB003 Supporting Advancement into Phase 1/2a Clinical Trial

VBI Vaccines Inc. today announced that PreHevbrio™ [Hepatitis B Vaccine (Recombinant)] is now available in the United States for the prevention of infection caused by all known subtypes of hepatitis B virus (HBV) in adults age 18 years and older.

UroGen Pharma Ltd. today announced that the U.S. Food and Drug Administration (FDA) has cleared UroGen’s Investigational New Drug (IND) application to begin a novel Phase 1 clinical study of the anti-CTLA-4 immunotherapy UGN-301 (zalifrelimab) in patients with recurrent NMIBC.

Aldeyra Therapeutics, Inc. today will announce at its 2022 Research & Development Day that three clinical trials of ADX-629, a first-in-class orally administered RASP modulator, generated signs of pharmacodynamic and clinical activity consistent with broad-based reduction in pathologic inflammation.

Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today announced dosing of the first patient in the Phase 1/2 STEADFAST clinical study evaluating TX200, a wholly-owned autologous Chimeric Antigen Receptor Regulatory T Cell (CAR-Treg) cell therapy product candidate for the prevention of immune-mediated rejection in HLA-A2 mismatched kidney transplantation from a living donor.

ReCor Medical Announces Completion of Enrollment in RADIANCE-II Pivotal Trial of the Paradise ™ Ultrasound Renal Denervation System for the Treatment of Uncontrolled Hypertension

Albireo Pharma, Inc. (Nasdaq: ALBO), a rare liver disease company developing novel bile acid modulators, today announced the completion of patient enrollment in the ASSERT study, a Phase 3 pivotal trial of Bylvay (odevixibat) in patients with Alagille syndrome (ALGS).

Bone replacement is a surgical procedure used to fix joints and bone damages caused due to severe orthopedic diseases and fractures. It is also performed for correction of deformities or as reconstruction to damaged or missing bones.

Elbow lesion are injuries that disrupt the cartilage and subjacent bone, and most commonly involve the capitellum. Factors that can result in elbow lesion include genetics, improper nutrition, and trauma.

Patient lifts have proven to be useful for disabled persons as well as caregivers. Disabled and elderly individuals face mobility issues while performing their day-to-day tasks, even finding the process to be dangerous most of the time.